Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

Medico Intercontinental Ltd - 539938 - Outcome Of Board Meeting And Compliances Of Regulation 30 And 33 Of SEBI (Listing Obligation And Disclosure Requirements) Regulation, 2015.

 Dear Sir/Ma'am, Pursuant to provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, this is to inform you that the Board of Directors of the Company at its meeting held today i.e., February 13, 2020, inter alia, considered and approved: 1. Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended on December 31, 2019 along with Limited Review report issued by M/s. V Goswami & Co, Statutory Auditors of the Company. Further, please find enclosed 'Unaudited Standalone and Consolidated Financial Results along with limited review report for the quarter and nine months ended on December 31, 2019' and same is also available on the website of the Company viz. www.medicointercontinental.com The Board Meeting of the Company commenced at 03:00 P.M and concluded at 03:45 PM. This is for your information and records.
13-02-2020
Bigul

Medico Intercontinental Ltd - 539938 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Dear Sir/Ma'am, Pursuant to Regulation 29 of SEBI (LODR) Regulations, 2015, we hereby inform you that meeting of Board of Directors is scheduled to be held on 13th February, 2020 to inter-alia consider, approve and take on record the unaudited financial results (Standalone & Consolidated) along with Limited review report for the quarter and nine months ended on 31st December, 2019. In continuation to the same, the newspaper clipping duly published in English Newspaper (Business Standard) and Gujarati Newspaper (Jai Hind) dated 6th February, 2020 is enclosed herewith. This is for your information and records.
06-02-2020
Bigul

Medico Intercontinental Ltd - 539938 - Board Meeting Intimation for Intimation Of Board Meeting In Compliance Of Regulation 29, 30 And 33 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

 Medico Intercontinental Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2020 ,inter alia, to consider and approve With reference to the captioned subject, we wish to inform you that the meeting of the Board of Directors of the Company is scheduled to be held on Thursday, 13th February, 2020 at the registered Office of the Company situated at 1-5th Floor, Adit Raj Arcade, Nr Karma Shreshtha Tower, 100 Ft Rd, Satellite, Ahmedabad, Gujarat - 380015, to inter alia consider, approve and take on record the unaudited Financial Results (Standalone and Consolidated) along with limited review report for quarter and nine months ended 31st December, 2019 and any other business items as per agenda circulated. You are requested to kindly take the same on your record.
05-02-2020
Bigul

Medico Intercontinental Ltd - 539938 - Shareholding for the Period Ended December 31, 2019

 Medico Intercontinental Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2019. For more details, kindly Click here
10-01-2020
Bigul

Medico Intercontinental Ltd - 539938 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 Dear Sir/ Madam, We are herewith enclosing the Confirmation Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended 31st December, 2019. Kindly take the above on your record.
09-01-2020
Bigul

Medico Intercontinental Ltd - 539938 - Statement Of Investor Complaints For The Quarter Ended December 2019

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- PUNEETA SHARMADesignation :- Company Secretary and Compliance Officer
08-01-2020
Bigul

Medico Intercontinental Ltd - 539938 - Closure of Trading Window

 Dear Sir / Ma'am Pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 and in compliance with circular no. LIST/COMP/01/2019-20 dated 2nd April, 2019 issued by BSE Limited, we wish to inform you that the 'Trading Window' for dealing in the securities of the Company has been closed and shall remain closed for all the designated persons and their immediate relatives till the conclusion of 48 hours after the declaration of financial results of the company for the quarter and nine months ended December 31, 2019. You are requested to disseminate the above information on your website.
31-12-2019
Bigul

Medico Intercontinental Ltd - 539938 - Request For Change In Details Under 'Corporate Information Tab' On The Website Of BSE.

 With respect to above mentioned subject and pursuant to earlier intimation given for proceedings of Extraordinary General Meeting dated 23rd March, 2019 for approval of shifting of Registered Office from the State of Maharashtra to Gujarat, we would like to inform that pursuant to such change, Master data of the Company on the website of Ministry of Corporate Affairs has been updated today. Therefore, we would like to request you to kindly update Corporate Information Tab of our Company on the website of BSE. The Changes are as per letter attached.
13-12-2019
Bigul

Medico Intercontinental Ltd - 539938 - Submission Of Disclosure Under Regulation 7(2) Read With Regulation 6(2) Of Securities Exchange Board Of India (Prohibition Of Insider Trading) Regulations 2015

 Dear Sir / Ma'am, Sub: Submission of Disclosure under Regulation 7(2) read with Regulation 6(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015. The Company has received disclosure dated 28th November, 2019 under Regulation 7(2) read with Regulation 6(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015 from Mr. Jay Sharadkumar Shah, Chief Financial Officer of the Company, being Person Acting in Concert (PAC) in respect of acquisition of Shares of Medico Intercontinental Limited by way of off-market purchase on 27th November, 2019. Accordingly, we are enclosing herewith copy of the above disclosure. You are kindly requested to take the same on record.
28-11-2019
Bigul

Medico Intercontinental Ltd - 539938 - Submission Of Disclosure Under Regulation 29(2) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations, 2011

 Dear Sir / Ma'am, Sub: Submission of Disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The Company has received disclosure dated 28th November, 2019 under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 from Mr. Jay Sharadkumar Shah, Chief Financial Officer of the Company, being Person Acting in Concert (PAC) in respect of acquisition of Shares of Medico Intercontinental Limited by way of off-market purchase on 27th November, 2019. Accordingly, we are enclosing herewith copy of the above disclosure. You are kindly requested to take the same on record.
28-11-2019
Next Page
Close

Let's Open Free Demat Account